There are 150 resources available
Comparison of resected vs. non-resected patients with unresectable locally advanced pancreatic cancer (LAPC) receiving P-32 microparticles with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy in the PanCO study
Presenter: Paul Ross, United Kingdom
Session: Session II: Cancer of the Pancreas
Resources:
Slides
Cases With Panel Discussion: Resectable, Borderline Resectable, and Unresectable Pancreatic Cancer
Presenter: Eric Van Cutsem, Belgium; Margaret Tempero, United States; Oliver Strobel, Austria; Karin Haustermans, Belgium; Gerald Prager, Austria; Maria Antonietta Bali, Belgium
Session: Session II: Cancer of the Pancreas
Resources:
Slides
New Treatment Options in Pancreatic Cancer
Presenter: Philip Philip, United States
Session: Session II: Cancer of the Pancreas
Resources:
Slides
Are We Making Progress in Targeting the Microenvironment and Immune System in PDAC?
Presenter: Eileen O'Reilly, United States
Session: Session II: Cancer of the Pancreas
Resources:
Slides
ESMO Vesalius Talk: How to find Local and International Mentors to Build Your Career in GI Oncology
Presenter: Claudia Cardone, Italy;Rille Pihlak, United Kingdom;Elene Mariamidze, Georgia;Andrés Cervantes, Spain;Sharlene Gill, Canada;Florian Lordick, Germany;Eileen O'Reilly, United States;Erika Ruiz-Garcia, Mexico;Naureen Starling, United Kingdom; Rille Pihlak, United Kingdom; Elene Mariamidze, Georgia; Andrés Cervantes, Spain; Sharlene Gill, Canada; Florian Lordick, Germany; Eileen O'Reilly, United States; Erika Ruiz-Garcia, Mexico; Naureen Starling, United Kingdom
Session: ESMO Vesalius Talk: How to find Local and International Mentors to Build Your Career in GI Oncology
Surgical Resection of Klatskin Tumors and Gall Bladder
Presenter: Thomas Gruenberger, Austria
Session: Session III: Cancer of the Biliary Tract
Resources:
Slides
Cases With Panel Discussion: Locally Advanced Biliary Tract Cancer
Presenter: Michel Ducreux, France; Angela Lamarca, Spain; Deborah Mukherji, United Arab Emirates; Thomas Gruenberger, Austria; Maria Antonietta Bali, Belgium
Session: Session III: Cancer of the Biliary Tract
Resources:
Slides
Outcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the Phase 3 TOPAZ-1 study
Presenter: Aiwu Ruth He, United States
Session: Session III: Cancer of the Biliary Tract
Resources:
Slides
Pemigatinib for previously treated locally advanced or metastatic cholangiocarcinoma: final results from FIGHT-202
Presenter: Arndt Vogel, Germany
Session: Session III: Cancer of the Biliary Tract
Resources:
Slides
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic-cholangiocarcinoma
Presenter: Margarita Rimini, Italy
Session: Session III: Cancer of the Biliary Tract
Resources:
Slides